Thymosin Beta 4 (TB500) (20mg) 80714-61-0 and angiogenic pathway signaling

and angiogenic pathway signaling

researchers may employ the formulation to examine concentration-response relationships

and formulation details to support method-level reproducibility and documentation control

• GHK-Cu Peptide Complex

Thymosin Beta 4 (TB500) (20mg) 80714-61-0 and angiogenic pathway signalingComposition and formatThymosin Beta 4 (TB500) (20 mg) is a research grade peptide supplied as a 20 mg lyophilized powder in a single vial. The batch specific Certificate of Analysis (COA) provides sequence confirmation, net peptide content, and formulation details to support method level reproducibility and documentation control. Analytical verificationEach lot is qualified at 99%+ purity by high performance liquid chromatography; identity is